Three Scenarios of the In Vitro Diagnostics Market, 2019-2023: Business-as-Usual, Economic Austerity, Technological Breakthroughs

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:

  • To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.

  • To identify key strategic decisions that will have to be made in the future.

  • To enhance corporate ability to develop realistic contingency plans.

  • To prepare executives to accommodate radically different operating climates and reduce surprises.

  • To challenge accepted perceptions of the future diagnostics market.

  • This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:

    - How will the future reimbursement changes affect individual market segments?

    - Will the industry consolidate, decentralize, or undergo a bimodal transformation?

    - What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?

    - How will the future technological advances affect the major market segment?

    - Which companies will enter the market and which will not survive?

    These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

    INTRODUCTION
    II. EXECUTIVE SUMMARY
    A. BUSINESS-AS-USUAL SCENARIO
    B. ECONOMIC AUSTERITY SCENARIO
    C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
    III. CONCLUSIONS AND RECOMMENDATIONS
    IV.THE SCENARIOS
    A. BUSINESS-AS-USUAL SCENARIO
    1. Business Environment
    a. Health Care Expenditures
    b. Cost-Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
    PPOs
    HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
    Chronic Illnesses
    Disease Incidence
    Susceptibility to Iatrogenesis
    Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
    2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
    Hospitals
    Commercial Laboratories
    Blood Banks
    Public Health Laboratories
    c. Decentralized Testing
    Personal Testing
    Physician Offices/Group Practices
    Ancillary Hospital Locations
    - ERs
    - ORs
    - ICUs/CCUs
    Cancer Clinics
    Ambulatory Care Centers
    Surgery Centers
    Nursing Homes
    Birth Centers
    3. Strategic Implications
    a. Testing Patterns
    Test Utilization
    Pre-Admission Testing
    Inpatient Testing
    Outpatient Testing
    4. Market Segments
    a. Chemistry and Immunoassay
    Introduction
    Future Situation
    b. Microbiology and Serology
    Introduction
    Future Situation
    c. Hematology and Flow Cytometry
    Introduction
    Future Situation
    d. Histology and Cytology
    Introduction
    Future Situation
    e. Coagulation
    Introduction
    Future Situation
    f. Urinalysis
    Introduction
    Future Situation
    g. Blood Banking
    Introduction
    Future Situation
    5.Technologies
    a. Genomics
    Introduction
    Future Situation
    b. Proteomics
    Introduction
    Future Situation
    c. DNA Probes
    Introduction
    Future Situation
    d. Biochips/Microarrays
    Introduction
    Future Situation
    e. Monoclonal Antibodies
    Introduction
    Future Situation
    f. Solid Phase Chemistry
    Introduction
    Future Situation
    g. Biosensors
    Introduction
    Future Situation
    h. Automation and Robotics
    Introduction
    Future Situation
    i. Computer-Aided Diagnosis
    Introduction
    Future Situation
    6.The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import-Export
    e. Potential Market Entrants
    f. Who May Not Survive?
    B. ECONOMIC AUSTERITY SCENARIO
    1. Business Environment
    a. Socio-Political Climate
    Cost-Consciousness
    Government Actions
    Three-Tier System
    Health Rationing
    Voucher System
    Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
    2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
    Ordering Practices
    Documentation
    Recertification
    b.Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
    3. Strategic Implications
    a. Testing Patterns
    Pre-Admission Testing
    Inpatient Testing
    Outpatient Testing
    b. Market Segments
    Chemistry and Immunoassay
    Microbiology and Serology
    Hematology and Flow Cytometry
    Histology and Cytology
    Coagulation
    Urinalysis
    Blood Banking
    c.Technologies
    Genomics
    Proteomics
    DNA Probes
    Biochips/Microarrays
    Monoclonal Antibodies and Immunoassays
    Automation and Robotics
    Solid Phase Chemistry
    Biosensors
    Computer-Aided Diagnosis
    d.The New Marketplace
    Purchasing Influences
    Marketing Strategies
    Joint Ventures, Mergers and Licensing
    Import-Export
    Potential Market Entrants
    Who May Not Survive?
    C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
    1. Business Environment
    a. Political/Regulatory Climate
    b. R & D Funding
    c. Industry-Government Relationship
    d. Industry-University Ventures
    e.Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
    2. Outlook for the In Vitro Diagnostics Market
    a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
    3. Strategic Implications
    a.Testing Patterns
    Pre-Admission Testing
    Inpatient Testing
    Outpatient Testing
    Test Volume and Market Size
    b. Market Segments
    Chemistry and Immunoassay
    Microbiology and Serology
    Hematology and Flow Cytometry
    Histology and Cytology
    Coagulation
    Urinalysis
    Blood Banking
    c.The New Marketplace
    Purchasing Influences
    Marketing Strategies
    Joint Ventures, Mergers and Licensing
    Import-Export
    Potential Market Entrants
    Who May Not Survive?
    V.APPENDICES: METHODOLOGY
    A.The Delphi
    B. Cross-Impact Analysis
    C. Substitution Modeling

    Executive Summary Table I: Business-As-Usual
    Scenario, Growth Areas in Clinical Laboratory
    Testing
    Executive Summary Table II: Economic Austerity
    Scenario, Growth Areas in Clinical Laboratory
    Testing
    Executive Summary Table III: Technological
    Breakthroughs Scenario, Growth Areas in
    Clinical Laboratory Testing
    Executive Summary Table IV: Market Size by Location
    Executive Summary Table V: Market Size by Laboratory
    Discipline
    Table-1: Business-As-Usual Scenario, Health
    Care Costs by Expenditure Type
    Table-2: Business-As-Usual Scenario, HMO and PPO
    Enrollment
    Table-3: Business-As-Usual Scenario, Selected
    Hospital Statistics
    Table-4: Business-As-Usual Scenario,Total Population
    and Physician Demographics
    Table-5: Business-As-Usual Scenario,Test Volume
    by Location
    Table-6: Business-As-Usual Scenario,Test Distribution
    by Location
    Table-7: Business-As-Usual Scenario, Market Size
    by Location
    Table-8: Business-As-Usual Scenario,Typical
    Pre-Admission Tests
    Table-9: Business-As-Usual Scenario,Test Volume
    by Laboratory Discipline
    Table-10: Business-As-Usual Scenario, Market Size
    By Laboratory Discipline
    Table-11: Economic Austerity Scenario, Selected
    Hospital Statistics
    Table-12: Economic Austerity Scenario,
    HMO and PPO Enrollment
    Table-13: Economic Austerity Scenario,Total Population
    and Physician Demographics
    Table-14: Economic Austerity Scenario, Major
    Categories of Overutilized Tests
    Table-15: Economic Austerity Scenario,
    Test Volume by Location
    Table-16: Economic Austerity Scenario,Test
    Distribution by Location
    Table-17: Economic Austerity Scenario,
    Market Size by Location
    Table-18: Economic Austerity Scenario,Timing
    Requirements for Selected Laboratory Tests
    Table-19: Economic Austerity Scenario,Test Volume
    by Laboratory Discipline
    Table-20: Economic Austerity Scenario, Market Size
    by Laboratory Discipline
    Table-21: Technological Breakthroughs Scenario, HMO
    and PPO Enrollment
    Table-22: Technological Breakthroughs Scenario,Total
    Population and Physician Demographics
    Table-23: Technological Breakthroughs Scenario,
    Selected Hospital Statistics
    Table-24: Technological Breakthroughs Scenario,
    Test Volume by Location
    Table-25: Technological Breakthroughs Scenario,
    Test Distribution by Location
    Table-26: Technological Breakthroughs Scenario,
    Market Size by Location
    Table-27: Technological Breakthroughs Scenario,
    Test Volume by Laboratory Discipline
    Table-28: Technological Breakthroughs Scenario,
    Market Size by Laboratory Discipline

    Three Scenarios of the Future In Vitro Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

    This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and Technologies that

    USD 9500 View Report

    Three Scenarios of the In Vitro Diagnostics Market, 2019-2023: Business-as-Usual, Economic Austerity, Technological Breakthroughs

    This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and technologies that

    USD 8500 View Report

    Three Scenarios of the Future In Vitro Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

    This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and Technologies that

    USD 9500 View Report

    In Vitro Diagnostics Industry 2021: Three Alternative Scenarios of the Future IVD Market--Business-as-Usual, Economic Austerity, Technological Breakthroughs

    This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and technologies that

    USD 14500 View Report

    Fill The Form For Sample Request

    Note : * Kindly provide us with your company id and get the sample reports at the earliest.

    There is no Reviews available